Seeking Alpha

Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 35 years executive experience including Abbott and JNJ and has been involved three successful start-ups. Before starting Raygent and other companies he was also a... More
My company:
Raygent Capital
My blog:
Raygent.com,Rayno Life Science
  • Rayno Biopharmaceutical Stocks Q1 2014 Performance 0 comments
    Apr 1, 2014 5:52 PM | about stocks: ABBV, ARIA, GILD

    Rayno Biopharmaceutical Portfolio 3/31/14

    Most of our biotech picks did well in a tough quarter that went through a severe correction in early February and again in late March. Many small and mid-cap momentum stocks were crushed but indices (FBT,IBB) overall held the early February technical levels. Use the two ETFs and FBIOX for re-balancing portfolios.

    Our top winners for the first quarter were :

    Albany Molecular (NASDAQ:AMRI) up 81%!, Alexion (NASDAQ:ALXN) up 14.3%, Seattle Genetics (NASDAQ:SGEN) up 11.6%, and Alkermes (NASDAQ:ALKS) up 10.2%.

    The top losers were:

    Pharmacyclics (NASDAQ:PCYC) down 5.7%, Gilead Sciences (NASDAQ:GILD) down 5.5% and Vertex (NASDAQ:VRTX) down 4.9%.

    We added three new stocks: Abbvie (NYSE:ABBV) an Abbott spin-off large cap biotech, Ariad (ARIA a small cap biotech and ROCHE Holdings (OTCQX:RHHBY) a leading large cap drug and diagnostic Company. We also recommended increasing the cash position to 20% early in the corrective phase. Keep in mind that most biotech stocks were up about 60% in 2013.

    Biotech stocks are now in a two day rally moving many stocks up 5%. We will review our diagnostic and tools portfolio later this week.

    Rayno Biopharmaceutical Picks

    2014 OriginalPPricePricePrice% RetPrice% Ret 
    SummaryTickerRecomm Apr'11Dec'12Nov'1311/1/133/31/14YTD 
               
    AbbvieABBV3/25/1451.7new   51.40 
    AchillionACHN3/4/138.6new 2.53-683.3-1.5 
    AlexionALXN2/2/0935100.895.4123.42.26153.1314.3 
    AlkermesALKS3/22/1323new18.535.659.2944.0910.2 
    Albany MolAMRI2/10/114.684.325.313.2140.718.5981 
    AriadARIA3/25/147.61new   8.065.9 
    AstexASTX*12/27/111.63 2.78.549.48acq  
    AmgenAMGN2/2/09555487.4118.713.1123.348 
    BiogenBIIB2/2/0948.573.2514924348.85305.879.4 
    CephalonCEPH*2/2/0976.576.9280.18 30acq  
    CubistCBST2/2/0921.528.3542.461.919.273.156.3 
    FT Arca ETFFBT4/15/1037.541.34664.629.676.711 
    GileadGILD2/2/095142.872.7(s)7140.6770.86-5.5 
    iShares ETFIBB2/2/0970.5101.1137.820629.9236.33.8 
    Fido BiotechFBIOX      194.857.22 
    ImmunoGenIMGN12/22/1112.4 12.516.334.814.931.9 
    OptimerOPTR*2/18/1111.813.89.212.860acq  
    PharmacyclPCYC6/8/1238.2 5812247.8100.22-5.7 
    RegeneronREGN2/2/0917.545.4317328634.5300.289.1 
    Roche ADRRHHBY1/30/1467new   37.75(s)7.7 
    Seattle Gen.SGEN2/2/099.515.7223.3394145.5611.6 
    VertexVRTX11/15/1362.8new   70.65-4.9 
    ViroPharmaVPHM*2/2/091220.0522.93929.4acq  
               
    *acquired          

    Chart forFirst Trust NYSE Arca Biotech Index (NYSEARCA:<a href='http://seekingalpha.com/symbol/fbt' title='First Trust NYSE Arca Biotechnology Index ETF'>FBT</a>)

    Disclosure: I am long ABBV, ARIA, GILD, ACHN.

    Additional disclosure: Long FBIOX.

    Stocks: ABBV, ARIA, GILD
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.